Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 50: 2386-2389, 2004; 10.1373/clinchem.2004.035774
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Florio, P.
Right arrow Articles by Gazzolo, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Florio, P.
Right arrow Articles by Gazzolo, D.
Related Collections
Right arrow Pediatric Clinical Chemistry
Right arrow Evidence Based Laboratory Medicine and Test Utilization
Right arrow Proteomics and Protein Markers
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2004;50:2386-2389.)
© 2004 American Association for Clinical Chemistry, Inc.


Technical Briefs

Cerebrospinal Fluid Activin A Measurement in Asphyxiated Full-Term Newborns Predicts Hypoxic Ischemic Encephalopathy

Pasquale Florio1, Stefano Luisi1, Matteo Bruschettini2, Dariusz Grutzfeld3, Anna Dobrzanska3, Pierluigi Bruschettini2, Felice Petraglia1,a and Diego Gazzolo2

1 Department of Pediatrics, Obstetrics and Reproductive Medicine, University of Siena, Siena, Italy
2 Department of Pediatrics, Giannina Gaslini Children’s University Hospital, Genoa, Italy
3 Department of Neonatology, Children’s Memorial Health Institute, Warsaw, Poland

aaddress correspondence to this author at: Department of Pediatrics, Obstetrics and Reproductive Medicine, University of Siena, Policlinico "Le Scotte", Viale Bracci, 53100 Siena, Italy; fax 39-0577-233-454, e-mail petraglia@unisi.it

The first 300 words of the full text of this article appear below.

Hypoxic ischemic encephalopathy (HIE) is an important cause of mortality and morbidity in full-term newborns, and neurologic handicaps develop in ~25–28% of these infants (1)(2). The postasphyxia period is crucial because brain damage may be at a subclinical stage or its symptoms may be hidden by the effects of sedation, and radiologic assessment may still be unrevealing (3)(4). Because activin A is a growth factor produced in the central nervous system (CNS) (5)(6), mainly after brain injury to modulate neuronal survival against toxicity (7)(8)(9)(10)(11)(12)(13)(14), in the present study we investigated whether its concentrations in cerebrospinal fluid (CSF) collected from asphyxiated full-term newborns were higher in those developing HIE and whether this measurement could be useful for the early detection of postasphyxia HIE.

We conducted a longitudinal cohort study, recruiting any infants consecutively admitted (April 1998 through June 2002) to our Neonatal Intensive Care Units (NICUs), who underwent a lumbar puncture in the first 24-h from birth for clinical indications. We expected approximately one third of asphyxiated infants to exhibit moderate/severe HIE; we therefore planned to enroll 30 infants in the asphyxiated group (full-term infants with a gestational age >36 weeks), with at least 8 of them in the HIE subgroup, which would assure a statistical power of 90% to detect differences ≥10% between group means with a significance level of 95%. Considering that <40% of the infants submitted to lumbar puncture in our NICUs have a history of perinatal asphyxia, we expected that ~40–50 nonasphyxiated infants could be enrolled to the control group contemporarily with the 30 infants of the asphyxiated group. The Local Ethics Committees approved the study protocol, and parents . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
P. Florio, R. Felipe Abella, T. de la Torre, A. Giamberti, S. Luisi, G. Butera, A. Cazzaniga, A. Frigiola, F. Petraglia, and D. Gazzolo
Perioperative Activin A Concentrations as a Predictive Marker of Neurologic Abnormalities in Children after Open Heart Surgery
Clin. Chem., May 1, 2007; 53(5): 982 - 985.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
P. Florio, S. Luisi, B. Moataza, M. Torricelli, I. Iman, M. Hala, A. Hanna, F. Petraglia, and D. Gazzolo
High Urinary Concentrations of Activin A in Asphyxiated Full-Term Newborns with Moderate or Severe Hypoxic Ischemic Encephalopathy
Clin. Chem., March 1, 2007; 53(3): 520 - 522.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
P. Florio, S. Perrone, S. Luisi, P. Vezzosi, M. Longini, B. Marzocchi, F. Petraglia, and G. Buonocore
Increased Plasma Concentrations of Activin A Predict Intraventricular Hemorrhage in Preterm Newborns
Clin. Chem., August 1, 2006; 52(8): 1516 - 1521.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.